Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-049221
Filing Date
2017-08-16
Accepted
2017-08-16 16:37:44
Documents
2
Period of Report
2017-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2240
2 POA DOCUMENT poa.txt EX-24.3_740682 3308
  Complete submission text file 0001209191-17-049221.txt   6877
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address PASSHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address
McMillan Scott T. (Reporting) CIK: 0001714676 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36294 | Film No.: 171036718